Merck and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s research

Contributed by: Business Wire

Logo

Images

(Photo: Business Wire)

Business Wire embedded0

Tags

Biotechnology

Health

Pharmaceutical

Clinical Trials

Oncology

Merck

More Like This

PR Newswire associated0

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays

bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease

Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson's Disease

PR Newswire associated0

Selonterra Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research

Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026

ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense

MRM Health Initiates Clinical Research in Parkinson’s Disease